- NEWS
COVID vaccines: head-to-head comparison reveals how they stack up
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
24,99 € / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
202,72 € per year
only 3,97 € per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
doi: https://doi.org/10.1038/d41586-022-00885-y
References
Zhang, Z. et al. Preprint at bioRxiv https://doi.org/10.1101/2022.03.18.484953 (2022).
Omicron thwarts some of the world’s most-used COVID vaccines
COVID vaccines to reach poorest countries in 2023 — despite recent pledges
Fourth dose of COVID vaccine offers only slight boost against Omicron infection
How well can Omicron evade immunity from COVID vaccines?
Vaccines protect against infection from Omicron subvariant — but not for long